Navigation Links
Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
Date:11/21/2008

10-Q.

Given these uncertainties, assumptions and risk factors, readers are cautioned not to place undue reliance on such forward-looking statements. Except as required by law, we disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained in this press release to reflect future results, events or developments.

(C)2008 Angiotech Pharmaceuticals, Inc. All Rights Reserved.

About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP) please visit our website at www.angiotech.com.


'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
2. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
3. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
4. Angiotech wins before the UK House of Lords
5. Angiotech to Establish Separate Operating and Royalty Businesses
6. Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
7. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
8. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
9. Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
10. Angiotech appoints Hank McKinnell to its Board of Directors
11. Angiotech to participate in Bank of America Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Martek Biosciences Corporation (Nasdaq: MATK ) announced today ... quarter and fiscal year 2009 on December 16, 2009, at ... at 4:45 p.m. ET Martek will conduct a conference call ... may listen to the call live via webcast by visiting ...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces that a ... its catalogue: ,, Carbondioxide Incubators - ... http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators are the ... cancer, research, and other applications for providing ...
(Date:12/2/2009)... demonstration tires made with BioIsoprene technology, a ... the manufacture of synthetic rubber with renewable biomass, made ... will be on display at a lounge in the ... December 21, while the other tire will make appearances ...
(Date:12/2/2009)... 2 , - ... , Coinciding with the ... Republic is hosting an international conference in Libreville,(Gabon) ... Africa. The,conference will be attended by government and ...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2
... today,announced that John Bennett, head of business development, ... during the Biotechnology Industry,Organization (BIO) International Convention in ... and an update on Celator,s clinical,development programs. The ... at 3:30 PDT in Room 3 of the ...
... Transaction reinforces Deloitte,s leading position in the life sciences ... ... June 16 Deloitte has announced today an,agreement to acquire Recombinant ... firm. Included in the,acquisition is Recap,s unique database that provides more ...
... ROSH HA,AYIN, Israel, June 16 ,EnzySurge Ltd. (EnzySurge), ... management, recently announced the formation of its,Scientific Advisory ... with diversified expertise in chronic wounds.,The Company named ... Diane L.,Krasner, PhD RN, FAAN, Joseph L. Mills, ...
Other Biology Technology:Deloitte Agrees to Acquire Recombinant Capital, A Leading Life Sciences Subscription Database and Advisory Services Firm 2EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board 2EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board 3EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board 4
(Date:12/4/2009)... Gardens, Kew and the Natural History Museum believe that ... previously thought, with many commonly grown plants such ... "meat eaters". A review paper, Murderous plants: Victorian Gothic, ... today (4 December 2009) in the Botanical Journal ...
(Date:12/4/2009)... Using a new mathematical model of heart cells, University ... critical enzyme, calmodulin kinase II (CaM kinase), disrupts the ... study, which also involved Columbia University, was published online ... . , "Recently, researchers have developed great interest ...
(Date:12/3/2009)... the 1980s, Harald zur Hausen and his co-workers discovered ... cancer. Scientists soon found out how these pathogens cause ... main culprits are viral proteins E6 and E7. Both ... cell growth. , Professor Dr. Frank Rsl and ...
Breaking Biology News(10 mins):Scientists think 'killer petunias' should join the ranks of carnivorous plants 2U-Iowa study helps advance heart-related research 2Papillomavirus silences innate immune response 2The Nations Largest Nonprofit Healthcare System Ascension Health Praises Step Forward in Health Reform Debate 57443 1The Nations Largest Nonprofit Healthcare System Ascension Health Praises Step Forward in Health Reform Debate 57443 2HealthSouth Announces Date of 2009 Third Quarter Earnings Conference Call 57441 1HealthSouth Announces Date of 2009 Third Quarter Earnings Conference Call 57441 2Health Insurance Reform DAILY MYTHBUSTER 3A Constitutionality of Health Insurance Reform 57439 1Health Insurance Reform DAILY MYTHBUSTER 3A Constitutionality of Health Insurance Reform 57439 2Health Insurance Reform DAILY MYTHBUSTER 3A Constitutionality of Health Insurance Reform 57439 3
... angina patients placed on beta-blocker therapy corresponds to specific ... researchers at Washington University School of Medicine in St. ... City. The study appears in the September 28, 2005 ... , "In our investigation of acute coronary syndrome (ACS) ...
... in the region now known as Uganda's Kibale ... a primate still in decline. The logging practice, ... ecological balance for these monkeys, leading to behavioral ... infections. , The researchers focused on three primate ...
... in the region now known as Uganda's Kibale ... a primate still in decline. The logging practice, ... ecological balance for these monkeys, leading to behavioral ... infections. , The researchers focused on three primate ...
Other Biology News:Survival of heart patients on beta-blockers varies greatly with genetic variation 2Survival of heart patients on beta-blockers varies greatly with genetic variation 3Survival of heart patients on beta-blockers varies greatly with genetic variation 4President Bush's cut to AIDS prevention in Africa would be devastating 2President Bush's cut to AIDS prevention in Africa would be devastating 3Affymetrix and ParAllele Launch Industry's Most Comprehensive Product Line for Targeted Genotyping 2Affymetrix and ParAllele Launch Industry's Most Comprehensive Product Line for Targeted Genotyping 3
Goat polyclonal to DRAK2...
Mouse monoclonal [0.N.509] to PCTAIRE2 ( Abpromise for all tested applications). entrezGeneID: 5128 SwissProtID: Q00537...
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: Western Blot...
Parathyroid Hormone Receptor 2 [PTHR2]...
Biology Products: